Abstract
Purpose. Fractal kinetics was used for the analysis of the carrier-mediated transport for drugs across the intestinal epithelial cells.
Methods. The transport was examined under various agitation rates using a monolayer of Caco-2 cells and rabbit ileum sheets.
Results. The passive transport of antipyrine across Caco-2 cells was increased with the increasing rate of agitation and was supposed to be caused by a change in the thickness of the unstirred water layer. On the contrary, in the case of L-lactic acid transport, which follows a carrier-mediated transport mechanism, the more the agitation rate controlling the fractal dimension was increased, the more the permeability rate across the Caco-2 cells was decreased. Fractal kinetic analysis of L-lactic acid transport indicated that the permeability was caused by a single saturable process. Similar agitation effects with L-lactic acid transport were observed in the transport of phenylalanine and cephradine in Caco-2 cells. However, the permeability rates of benzoic acid and 3-O-methyl-D-glucose across Caco-2 cells and L-lactic acid transport across the rabbit ileum tissue indicated the maximum levels at a designated agitation rate. This phenomenon was likely to be caused by the agitation effects controlling not only the fractal environment but also the unstirred water layer.
Conclusions. Carrier-mediated transports are well defined by fractal kinetics rather than classical kinetic analysis. Fractal kinetics are one of the important areas for understanding and confirming the properties of a carrier-mediated transport process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:963–977 (1996).
A. Tsuji, M. T. Simanjuntak, I. Tamai, and T. Terasaki. pH-dependent intestinal transport of monocarboxylic acids: Carrier-mediated and H+-cotransport mechanism versus pH-partition hypothesis. J. Pharm. Sci. 79:1123–1124 (1990).
M. T. Simanjuntak, I. Tamai, T. Terasaki, and A. Tsuji. Carrier-mediated uptake of nicotinic acid by rat intestinal brush-border membrane vesicles and relation to monocarboxylic acid transport. J. Pharmacobio-Dyn. 13:301–309 (1990).
M. T. Simanjuntak, T. Terasaki, I. Tamai, and A. Tsuji. Participation of monocarboxylic anion and bicarbonate exchange system for the transport of acetic acid and monocarboxylic acid drugs in the small intestinal brush-border membrane vesicles. J. Pharmacobio-Dyn. 14:501–508 (1991).
A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki. Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res. 11:30–37 (1994).
H. Takanaga, I. Tamai, and A. Tsuji. pH-Dependent and carrier-mediated transport of salicylic acid across Caco-2 cells. J. Pharm. Pharmacol. 46:567–570 (1994).
I. Tamai, H. Takanaga, T. Ogihara, M. Yoneda, and A. Tsuji. Proton-cotransport of pravastatin across intestinal brush-border membrane. Pharm. Res. 12:1727–1732 (1995).
T. Ogihara, I. Tamai, H. Takanaga, Y. Sai, and A. Tsuji. Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells. Pharm. Res. 13:1828–1832 (1996).
A. Tsuji. Peptide-Based Drug Design, Chapter 5: Intestinal Absorption of β-Lactam Antibiotics, M. D. Taylar and G. L. Amidon, ed., American Chemical Society (Washington, DC, 1995).
B. B. Brodie and C. A. M. Hogben. Some physico-chemical factors in drug action. J. Pharm. Pharmacol. 9:345–380 (1957). Res. 12:541–548 (1995).
P. Macheras, Carrier-mediated transport can obey fractcal kinetics. Pharm. Res. 12:541–548 (1995).
I. J. Hidalgo and R. T. Borchardt. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochem. Biophys. Acta 1028:25–30 (1990).
S. Matsumoto, H. Saito, and K. Inui. Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: Interaction with dipeptide transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 270:498–504 (1994).
S. T. Riley, G. Warhurst, P. T Crowe, and L. A. Turnberg. Active hexose transport across cultured human Caco-2 cells: characterization and influence of culture conditions. Biochem. Biophys. Acta 1066:175–182 (1991).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275 (1951).
K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn. 4:879–885 (1981).
H. Takanaga, I. Tamai, S. Inaba, Y. Sai, H. Higashida, H. Yamamoto, and A. Tsuji. cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter. Biochem. Biophys. Res. Commun. 217:370–377 (1995).
I. Tamai, H. Takanaga, H. Maeda, Y. Sai, T. Ogihara, H. Higashida, and A. Tsuji. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem. Biophys. Res. Commun. 214:482–489 (1995).
H. Takanaga, H. Maeda, H. Yabuuchi, I. Tamai, H. Higashida, and A. Tsuji. Nicotinic acid transport mediated by pH-dependent anion antiporter and proton cotransporter in rabbit intestinal brushborder membrane. J. Pharm. Pharmacol. 48:1073–1077 (1996).
I. Tamai, H. Takanaga, H. Maeda, H. Yabu-uchi, Y. Sai, Y. Suzuki, and A. Tsuji. Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion anitiport mechanisms. J. Pharm. Pharmacol. 49:108–112 (1997).
I. Tamai, N. Tomizawa, A. Kadowaki, T. Terasaki, K. Nakayama, H. Higashida, and A. Tsuji. Functional expression of intestinal small peptide/β-lactam antibiotic transporter in Xenopus laevis Oocytes, Biochem. Pharmacol. 48:881–888 (1994).
I. Tamai, N. Tomizawa, T. Takeuchi, K. Nakayama, H. Higashida, and A. Tsuji. Functional expression of transporter for β-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines. J. Pharm. Exp. Ther. 273:26–31 (1995).
I. Tamai, K. Hayashi, T. Terao, Y. Sai, T. Shiraga, K. Miyamoto, E. Takeda, H. Higashida, and A. Tsuji. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of β-lactam antibiotics in the rat small intestine. J. Pharm. Pharmacol. 49:796–801 (1997).
T. Ishizawa, S. Sadahiro, K. Hosoi, I. Tamai, T. Terasaki, and A. Tsuji Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans J. Pharmacobio-Dyn. 15:481–489 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ogihara, T., Tamai, I. & Tsuji, A. Application of Fractal Kinetics for Carrier-Mediated Transport of Drugs Across Intestinal Epithelial Membrane. Pharm Res 15, 620–625 (1998). https://doi.org/10.1023/A:1011994230346
Issue Date:
DOI: https://doi.org/10.1023/A:1011994230346